COVID-19 Patients with Hepatitis B Super-Infection
Author Information
Author(s): Yu Shan, Song Cunzheng
Primary Institution: Shanghai Jiao Tong University School of Medicine, Ren Ji Hospital
Hypothesis
Does HBV super-infection worsen liver function and disease prognosis in COVID-19 patients?
Conclusion
HBV super-infection slightly affects liver function but does not worsen COVID-19 outcomes.
Supporting Evidence
- 37 out of 249 COVID-19 patients were super-infected with HBV.
- Patients with HBV super-infection had lower white blood cell, neutrophil, and platelet counts.
- Total bilirubin levels were significantly higher in the HBV super-infected group.
Takeaway
This study looked at COVID-19 patients who also had hepatitis B and found that having both didn't make their COVID-19 worse, but it did affect their liver a little.
Methodology
Retrospective analysis of clinical characteristics, laboratory data, and treatment outcomes of COVID-19 patients with and without HBV super-infection.
Potential Biases
Potential biases due to retrospective design and selection criteria.
Limitations
The study is limited to a single center and may not be generalizable to all populations.
Participant Demographics
Patients aged 18 to 80 years, with 55.8% men.
Statistical Information
P-Value
0.022
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website